BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/28/2024 6:35:33 AM | Browse: 354 | Download: 843
 |
Received |
|
2024-07-04 19:36 |
|
Peer-Review Started |
|
2024-07-04 19:36 |
|
First Decision by Editorial Office Director |
|
2024-10-22 08:38 |
|
Return for Revision |
|
2024-10-22 08:38 |
|
Revised |
|
2024-11-04 05:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-11-18 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-19 10:16 |
|
Articles in Press |
|
2024-11-19 10:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-21 00:41 |
|
Publish the Manuscript Online |
|
2024-11-28 03:06 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Editorial |
| Article Title |
Dexamethasone in coronavirus disease 2019 care: Dosage and utilization insights
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Laiba Shamim, Imshaal Musharaf and Abdulqadir J Nashwan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdulqadir J Nashwan, PhD, Department of Nursing and Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa |
| Key Words |
COVID-19; Severe acute respiratory syndrome; Corticosteroid; Dexamethasone; Anti-inflammatory |
| Core Tip |
This editorial evaluates a meta-analysis comparing high-dose and low-dose dexamethasone in the treatment of coronavirus disease 2019 (COVID-19) patients. The study reveals no significant differences in adverse effects and mortality between the dosing regimens. In line with the current guidelines, the study favors using low-dose dexamethasone but highlights the call for additional research on high-dose dexamethasone’s benefits. The study includes limitations such as a lack of long-term data and heterogeneity of the included studies. It is crucial to address these gaps in the future to optimize treatment strategies for COVID-19. |
| Publish Date |
2024-11-28 03:06 |
| Citation |
Shamim L, Musharaf I, Nashwan AJ. Dexamethasone in coronavirus disease 2019 care: Dosage and utilization insights. World J Virol 2025; 14(1): 98765 |
| URL |
https://www.wjgnet.com/2220-3249/full/v14/i1/98765.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v14.i1.98765 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
